A prospective study to evaluate efficacy and safety of levonorgestral intrauterine device (Mirena) combined with gonadotropin-releasing hormone agonist (Zoladex) in female patients with grade 1 endometrial carcinoma and the levonorgestrel monotherapy in female patients with complex atypical hyperplasia

Trial Profile

A prospective study to evaluate efficacy and safety of levonorgestral intrauterine device (Mirena) combined with gonadotropin-releasing hormone agonist (Zoladex) in female patients with grade 1 endometrial carcinoma and the levonorgestrel monotherapy in female patients with complex atypical hyperplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Goserelin (Primary) ; Levonorgestrel (Primary)
  • Indications Atypical endometrial hyperplasia; Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top